You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

04-144

Showing 1 - 25 of 2,487
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Normal Skin and Acne Vulgaris Patients

Active, not recruiting
  • Acne Vulgaris
    • Jakarta Pusat, DKI Jakarta, Indonesia
    • +1 more
    Apr 28, 2023

    Painful Diabetic Neuropathy Trial in Worldwide (trazodone/gabapentin 2.5/25 mg, trazodone/gabapentin 5/50 mg,

    Completed
    • Painful Diabetic Neuropathy
    • trazodone/gabapentin 2.5/25 mg
    • +4 more
    • Litomyšl, 570 01, Czechia
    • +29 more
    May 26, 2021

    Post-herpetic Neuralgia Trial in Worldwide (EMA401, Placebo)

    Terminated
    Has Results
    • Post-herpetic Neuralgia
    • Melbourne, Victoria, Australia
    • +57 more
    Oct 7, 2021

    Erosive Esophagitis Trial in Worldwide (X842, X842 Dummy, Lansoprazole)

    Recruiting
    • Erosive Esophagitis
    • DeBary, Florida
    • +66 more
    Jun 10, 2022

    Gastric Cancer Trial in Worldwide (Bemarituzumab, Placebo, Modified FOLFOX6)

    Completed
    Has Results
    • Gastric Cancer
    • Bemarituzumab
    • +2 more
    • Tucson, Arizona
    • +188 more
    Dec 15, 2022

    Dementia Trial (CoMPoSER intervention group, Sleep Education)

    Not yet recruiting
    • Dementia
    • CoMPoSER intervention group
    • Sleep Education
    • (no location specified)
    Oct 12, 2023

    Moderate to Severe Atopic Dermatitis Trial in Worldwide (ISB 830 - Part 1 Group 1, ISB 830 - Part 1 Group 2, ISB 830 - Part 1

    Completed
    Has Results
    • Moderate to Severe Atopic Dermatitis
    • ISB 830 - Part 1 Group 1
    • +5 more
    • Birmingham, Alabama
    • +82 more
    Jul 26, 2022

    Parkinson Disease Trial in United States (BIIB122, BIIB122-Matching Placebo)

    Recruiting
    • Parkinson Disease
    • Englewood, Colorado
    • +4 more
    Aug 17, 2022

    HIV Trial in Worldwide (DTG + 3TC, TAF based regimen (TBR))

    Completed
    Has Results
    • HIV Infections
    • DTG + 3TC
    • TAF based regimen (TBR)
    • Phoenix, Arizona
    • +132 more
    Jun 27, 2022

    Rectal Cancer Trial in Wuhan (68Ga-FAPI-04, 18F-FDG)

    Recruiting
    • Rectal Cancer
    • Wuhan, Hubei, China
      China, Hubei Province
    Aug 11, 2023

    Type 1 Diabetes Trial in Neuss (Euglycemic clamp with BC Combo THDB0207, Euglycemic clamp with Lantus®, Euglycemic clamp with

    Recruiting
    • Type 1 Diabetes
    • Euglycemic clamp with BC Combo THDB0207
    • +2 more
    • Neuss, Germany
      Profil Institut für Stoffwechselforschung GmbH
    Jun 23, 2022

    Tumor, Solid Trial in Nanchong (Radiation: 18F-AlF-FAPi-04, Radiation: 18F-FDG)

    Recruiting
    • Tumor, Solid
    • Radiation: 18F-AlF-FAPi-04
    • Radiation: 18F-FDG
    • Nanchong, Sichuan, China
      Affiliated Hospital of North Sichuan Medical College
    Nov 6, 2023

    Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck, NSCLC Trial in Worldwide (Lifileucel, LN-145, Pembrolizumab)

    Recruiting
    • Metastatic Melanoma
    • +2 more
    • Lifileucel
    • +5 more
    • La Jolla, California
    • +44 more
    Dec 16, 2022

    Anemia in Chronic Kidney Disease in Non-dialysis Patients Trial in Worldwide (Roxadustat, Darbepoetin alfa)

    Completed
    Has Results
    • Anemia in Chronic Kidney Disease in Non-dialysis Patients
    • Vienna, Austria
    • +124 more
    Apr 19, 2021

    Necrotic Pulp Trial (Root canal instrumentation EdgeFile X7 to size #35/0.06, Root canal instrumentation EdgeFile X7 to size

    Not yet recruiting
    • Necrotic Pulp
    • Root canal instrumentation EdgeFile X7 to size #35/0.06
    • +3 more
    • (no location specified)
    Nov 16, 2022

    Metabolic Syndrome, Pre-diabetes, Overweight and Obesity Trial in Kiel, Cork (Pasteurized A. muciniphila, )

    Recruiting
    • Metabolic Syndrome
    • +2 more
    • Pasteurized A. muciniphila
    • placebo
    • Kiel, Germany
    • +1 more
    Sep 14, 2022

    Papulopustular Rosacea Trial in Canada (Lotilaner Gel, 2.0%, Vehicle control gel)

    Recruiting
    • Papulopustular Rosacea
    • Lotilaner Gel, 2.0%
    • Vehicle control gel
    • Oakville, Ontario, Canada
    • +4 more
    Apr 20, 2023

    18F-FAPI, 18F-FDG, Pancreas Adenocarcinoma Trial in Hangzhou (18F-FAPI, 18F-FDG)

    Completed
    • 18F-FAPI
    • +4 more
    • Hangzhou, Zhejiang, China
      the First Affiliated Hospital, School of Medicine, Zhejiang Univ
    May 31, 2023

    Oral Carcinoma Trial in Beijing (68Ga-FAPI-04)

    Recruiting
    • Oral Carcinoma
    • Beijing, Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medica
    Oct 26, 2022

    Metastatic Melanoma Trial in New York (Lifileucel (LN-144))

    Recruiting
    • Metastatic Melanoma
    • Lifileucel (LN-144)
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Jan 23, 2023

    Breast Cancer Trial in Suzhou ([14C] TQB3616)

    Not yet recruiting
    • Breast Cancer
    • [14C] TQB3616
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Nov 21, 2023

    Recommendations in Patients With Lynch Syndrome

    Recruiting
    • Lynch Syndrome
    • questionnaires, telephone interview, optional blood drawn
    • questionnaires, telephone interview and optional blood drawn
    • Basking Ridge, New Jersey
    • +7 more
    Mar 23, 2022

    Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))

    Recruiting
    • Uveal Melanoma
    • +3 more
    • Lifileucel (LN-144)
    • Harrison, New York
    • +1 more
    Nov 8, 2022

    COVID-19 Trial in United States (mRNA-CR-04 vaccine 10µg, mRNA-CR-04 vaccine 30µg, mRNA-CR-04 vaccine 100µg)

    Not yet recruiting
    • COVID-19
    • mRNA-CR-04 vaccine 10μg
    • +3 more
    • San Diego, California
    • +3 more
    Aug 1, 2023

    Low Back Pain, Sciatica Trial in Petach Tikva (BOL-DP-o-04 + SCO, Placebo + SCO)

    Completed
    • Low Back Pain
    • Sciatica
    • BOL-DP-o-04 + SCO
    • Placebo + SCO
    • Petach Tikva, Israel
      Beilinson Medical Center
    Dec 7, 2022